Bausch and Lomb Revenue and Competitors
Estimated Revenue & Valuation
- Bausch and Lomb's estimated annual revenue is currently $2.6B per year.
- Bausch and Lomb's estimated revenue per employee is $251,000
Employee Data
- Bausch and Lomb has 10360 Employees.
- Bausch and Lomb grew their employee count by 6% last year.
Bausch and Lomb Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.8M | 31 | 11% | N/A | N/A |
#2 | $12.3M | 49 | -4% | N/A | N/A |
#3 | $15.1M | 60 | 7% | N/A | N/A |
#4 | $8.8M | 35 | -8% | N/A | N/A |
#5 | $3M | 12 | 9% | N/A | N/A |
#6 | $300.4M | 1197 | 3% | N/A | N/A |
#7 | $311.7M | 1242 | 2% | N/A | N/A |
#8 | $0.3M | 1 | -96% | N/A | N/A |
#9 | $8.3M | 33 | 3% | N/A | N/A |
#10 | $13.6M | 54 | 8% | N/A | N/A |
What Is Bausch and Lomb?
Bausch & Lomb Incorporated is the preeminent global technology-based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology. Its core businesses include soft and rigid gas permeable contact lenses, lens care products, ophthalmic surgical and pharmaceutical products. The company is advantaged with some of the most respected brands in the world starting with its name, Bausch & Lomb, and including SofLens, PureVision, Boston, ReNu, Storz and Technolas.
keywords:N/AN/A
Total Funding
10360
Number of Employees
$2.6B
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bausch and Lomb's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Sales - OTC | Reveal Email/Phone |
2 | Senior Human Resources Director | Reveal Email/Phone |
3 | Executive Director, Medical Affairs - Vision Care | Reveal Email/Phone |
4 | VP Global Procurement | Reveal Email/Phone |
5 | Chemistry Supervisor | Reveal Email/Phone |
6 | Director, Finance Systems | Reveal Email/Phone |
7 | Director, Advanced Design | Reveal Email/Phone |
8 | EDI Specialist | Reveal Email/Phone |
9 | Senior Ocular Specialty Representative | Reveal Email/Phone |
10 | Regional Account Director | Reveal Email/Phone |
Bausch and Lomb News
Shares of Bausch Health Cos. Inc. BHC, -0.91% shed 0.91% to C$27.32 Monday, in what proved to be an all-around negative trading session for...
(NYSE/TSX: BHC) ("Bausch Health"), and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today...
Bausch Health , the specialty pharma company, is making progress in tackling its indebtedness. Bausch (ticker: BHC) said Wednesday that its...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $38500M | 103675 | 2% | N/A |